Showing results (1-10 of 10) with videos related to

Sort By:
Pageof 1
Vaccine|April 18, 2015
Immunogenicity and reactogenicity of a decennial booster dose of a combined reduced-antigen-content diphtheria-tetanus-acellular pertussis and inactivated poliovirus booster vaccine (dTpa-IPV) in healthy adultsMartina Kovac, Niraj Rathi, Sherine Kuriyakose, et al.
Vaccine|January 24, 2015
Decennial administration in young adults of a reduced-antigen content diphtheria, tetanus, acellular pertussis vaccine containing two different concentrations of aluminiumCorinne Vandermeulen, Heidi Theeten, Niraj Rathi, et al.
Canadian Journal of Physiology and Pharmacology|April 18, 2008
Alteration of superoxide- and nitric oxide-mediated antimicrobial function of macrophages by in vivo cocaine exposureAsok K Tripathi, Niraj Rathi, Sanvidhan G Suke, et al.
Human Vaccines & Immunotherapeutics|September 10, 2013
Human rotavirus vaccine (RIX4414) efficacy in the first two years of life: a randomized, placebo-controlled trial in ChinaRong-cheng Li, Teng Huang, Yanping Li, et al.
Human Vaccines & Immunotherapeutics|May 6, 2016
Immunogenicity and reactogenicity of the human rotavirus vaccine, RIX4414 oral suspension, when co-administered with routine childhood vaccines in Chinese infantsRong-Cheng Li, Teng Huang, Yanping Li, et al.
Vaccines|November 26, 2024
Measles-Rubella Microarray Patches Phase III Clinical Trial Framework: Proposal and ConsiderationsDarin Zehrung, Bruce L Innis, Auliya A Suwantika, et al.
Therapeutic Advances in Vaccines and Immunotherapy|June 11, 2020
Safety and immunogenicity of a seasonal trivalent inactivated split influenza vaccine: a double blind, phase III randomized clinical trial in healthy Serbian adultsGoran Stevanovic, Aleksandar Obradovic, Snezana Ristic, et al.
Lancet (London, England)|November 17, 2025
Safety and immunogenicity of a Nipah virus vaccine (HeV-sG-V) in adults: a single-centre, randomised, observer-blind, placebo-controlled, phase 1 studyRobert W Frenck, Abdi Naficy, Jodi Feser, et al.
Vaccine|November 14, 2018
A Phase III open-label, randomized, active controlled clinical study to assess safety, immunogenicity and lot-to-lot consistency of a bovine-human reassortant pentavalent rotavirus vaccine in Indian infantsNiraj Rathi, Sajjad Desai, Anand Kawade, et al.
Vaccine|August 15, 2018
Non-interference of Bovine-Human reassortant pentavalent rotavirus vaccine ROTASIIL® with the immunogenicity of infant vaccines in comparison with a licensed rotavirus vaccineSajjad Desai, Niraj Rathi, Anand Kawade, et al.
Pageof 1